Carbylan Therapeutics' IPO

Carbylan Therapeutics raised a round of funding on April 09, 2015. Investors include Public.

Carbylan Therapeutics is a clinical-stage, specialty, pharmaceutical company focused on the development and commercialization of proprietary combination therapies that address significant unmet medica…

Articles about Carbylan Therapeutics' IPO: